PUBLICATION

Tumor necrosis factor induces pathogenic mitochondrial ROS in tuberculosis through reverse electron transport

Authors
Roca, F.J., Whitworth, L.J., Prag, H.A., Murphy, M.P., Ramakrishnan, L.
ID
ZDB-PUB-220624-18
Date
2022
Source
Science (New York, N.Y.)   376: eabh2841 (Journal)
Registered Authors
Ramakrishnan, Lalita, Roca, Francisco Jose
Keywords
none
MeSH Terms
  • Animals
  • Citric Acid Cycle/drug effects
  • Electron Transport
  • Electron Transport Complex I*/antagonists & inhibitors
  • Electron Transport Complex I*/metabolism
  • Humans
  • Macrophages*/metabolism
  • Macrophages*/microbiology
  • Macrophages*/pathology
  • Metformin*/pharmacology
  • Mycobacterium tuberculosis*/metabolism
  • Necrosis
  • Reactive Oxygen Species*/metabolism
  • Succinic Acid/metabolism
  • Tuberculosis*/metabolism
  • Tuberculosis*/microbiology
  • Tuberculosis*/pathology
  • Tumor Necrosis Factor-alpha*/metabolism
  • Zebrafish
PubMed
35737799 Full text @ Science
Abstract
Tumor necrosis factor (TNF) is a critical host resistance factor against tuberculosis. However, excess TNF produces susceptibility by increasing mitochondrial reactive oxygen species (mROS), which initiate a signaling cascade to cause pathogenic necrosis of mycobacterium-infected macrophages. In zebrafish, we identified the mechanism of TNF-induced mROS in tuberculosis. Excess TNF in mycobacterium-infected macrophages elevates mROS production by reverse electron transport (RET) through complex I. TNF-activated cellular glutamine uptake leads to an increased concentration of succinate, a Krebs cycle intermediate. Oxidation of this elevated succinate by complex II drives RET, thereby generating the mROS superoxide at complex I. The complex I inhibitor metformin, a widely used antidiabetic drug, prevents TNF-induced mROS and necrosis of Mycobacterium tuberculosis-infected zebrafish and human macrophages; metformin may therefore be useful in tuberculosis therapy.
Genes / Markers
Figures
Show all Figures
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Antibodies
Orthology
Engineered Foreign Genes
Mapping